Positive Phase I clinical data for oral COVID-19 vaccine
ADC评论
October 9, 2022
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine -Primary and secondary endpoints of safety and immunogenicity met -Oral vaccine
